Resveratrol enhances polyubiquitination-mediated ARV7 degradation in prostate cancer cells.

about

Resveratrol enhances polyubiquitination-mediated ARV7 degradation in prostate cancer cells.

Item

http://www.wikidata.org/entity/Q41551014

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Resveratrol enhances polyubiqu ...... tion in prostate cancer cells.

@en

type

Item

label

Resveratrol enhances polyubiqu ...... tion in prostate cancer cells.

@en

prefLabel

Resveratrol enhances polyubiqu ...... tion in prostate cancer cells.

@en

P1476

Resveratrol enhances polyubiqu ...... ation in prostate cancer cells

@en

P2093

Dali Tong

http://www.w3.org/2001/XMLSchema#string

Dianzheng Zhang

http://www.w3.org/2001/XMLSchema#string

Jing Xu

http://www.w3.org/2001/XMLSchema#string

Jun Jiang

http://www.w3.org/2001/XMLSchema#string

Kyla Geary

http://www.w3.org/2001/XMLSchema#string

Lucia Cavero

http://www.w3.org/2001/XMLSchema#string

Nicholas Talamonti

http://www.w3.org/2001/XMLSchema#string

Qiuli Liu

http://www.w3.org/2001/XMLSchema#string

Sarah Wilson

http://www.w3.org/2001/XMLSchema#string

P2860

New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathway

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer

Cancer statistics, 2015

Alcohol consumption and risk of prostate cancer in middle-aged men

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

Grape-derived chemopreventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by an androgen receptor (AR)-independent mechanism

Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.

AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression

P304

54683-54693

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18003

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Junjiang Fu

P577

2017-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28903374

http://www.w3.org/2001/XMLSchema#string

P932

5589613

http://www.w3.org/2001/XMLSchema#string